EUCTR2011-006113-34-ES进行中（未招募）不适用
Effect of pioglitazone administred to patients with Adrenomyeloneuropathy: A phase II, Singlearm, Monocentric Trial. - Pioglitazone in Adrenomyeloneuropathy
AURORA PUJOL ONOFRE0 个研究点开始时间: 2013年9月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Men and women of 18 to 65 years old, inclusive.Clinical signs of AMN with at least pyramidal signs in the lower limbs and difficulties to run.Presence of motor deficit according to the EDSS scale. Ability to perform the 6MWT
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Gadolinium enhancement on T1 sequence of any abnormal hypersignal of white matter, including myelinated pyramidal tracts, visible at brain MRI on FLAIR sequences.History of heart failure or cardiac disease.Prior or current bladder cancer. Women with history of osteoporosis. Gross hematuria of unknown origin.
研究者
相似试验
招募中
不适用
The effect of pioglitazone on reducing methamphetamine dependence.Methamphetamine dependent patients.IRCT20190427043389N1Zanjan University of Medical Sciences100
招募中
不适用
The effect of pioglitazone on reducing opioid and heroin dependence.IRCT20190427043389N2Zanjan University of Medical Sciences100
已完成
2 期
Comparison the treatment effect of Pioglithazone with Metformin in patients withNon Alcoholic SteatoHepatitis (NASH)Fatty liver.fatty (change of) liver, not elsewhere classifiedIRCT201105026361N1Vice chancellor for research, Kashan University of Medical Sciences and Health Services80
招募中
3 期
Effect of Pioglitazone and ClobetasolIRCT20210926052596N1Tehran University of Medical Sciences40
已完成
2 期
Pioglitazone the treatment of schizophreniaschizophrenia.schizophreniaIRCT201110281556N30Tehran University of Medical Sciences30